Does medical cannabis relieve back pain?

Evidence is limited. The strongest data comes from chronic pain research, not back pain research. A 2017 review by the National Academies of Sciences, Engineering, and Medicine found substantial evidence that cannabis relieves chronic pain in adults. A 2018 Cochrane review of cannabis-based medicines found low-quality evidence of modest pain relief. None of the trials in that review enrolled people with back pain alone. No large randomized trial has tested smoked cannabis flower for low back pain.

medical cannabis for back pain relief

That leaves back pain patients with indirect evidence and a wide range of personal response.

read more

What the trials measured

Most clinical trials used pharmaceutical cannabinoids: nabilone, dronabinol, and nabiximols. Conditions were neuropathic pain, multiple sclerosis spasticity, and cancer pain. A 2015 meta-analysis in JAMA pooled 79 trials and rated the evidence quality as low to moderate. Pain score drops were small on a 0 to 10 scale. Response rates above placebo were modest.

Cannabis Oil for Back Pain: Benefits, Risks, and Safe Use

Back pain has two common drivers: nociceptive signals from joints and discs, and nerve compression that causes radicular pain. Cannabinoids act on CB1 and CB2 receptors in the nervous system. Researchers have studied the nerve pain pathway more than the mechanical pathway.

THC for Chronic Back Pain: A Buying Guide for Legal Markets

Forms and how they differ

Products carry different THC to CBD ratios. THC drives the psychoactive effect and most of the side effects. CBD does not produce a high. Some patients report better tolerance with a ratio near 1:1.

Dosing basics

Start low. A common starting point is 1 to 2 mg of THC or 2.5 to 5 mg of CBD. Wait at least 2 hours before a second oral dose. Keep a written log of dose, time, pain score, and side effects.

Potency has changed. Federal monitoring data show average THC in confiscated cannabis flower rose from about 4 percent in 1995 to above 15 percent by 2019. A 2020s product is not the same as a 1990s product.

Risks and limits

Legal status in the US

Cannabis remains a Schedule I substance under federal law. State medical programs require certification from a licensed clinician and a state-issued card. Possession limits, home grow rules, and product testing requirements differ by state. A state card does not transfer across state lines.

The FDA has not approved cannabis flower for any medical use. It has approved purified CBD (Epidiolex) for rare seizure disorders and synthetic cannabinoids (dronabinol, nabilone) for chemotherapy nausea and appetite loss.

Questions for a clinician

  1. Is my back pain nociceptive, neuropathic, or both?
  2. Which of my current medicines interact with cannabinoids?
  3. What dose should I start with, and how long before I judge the result?
  4. Which form fits my symptoms and daily schedule?
  5. What side effects should make me stop?